Catheter Precision, Inc. Secures Initial Orders for LockeT from Prominent Hospitals

Catheter Precision, Inc., a medical device company specializing in electrophysiology products, announced initial orders for its new product, LockeT, from notable medical institutions including Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego. This announcement follows the expansion of the company's U.S. sales and clinical team in anticipation of LockeT's national launch.

David Jenkins, CEO of Catheter Precision, highlighted the increase in LockeT evaluations and purchase orders following the expansion of the commercial team. Marie-Claude Jaques, the Chief Commercial Officer, noted the addition of eight new representatives and several hospitals lined up for upcoming LockeT evaluations. LockeT, a Class 1 FDA-registered device, facilitates hemostasis after vascular catheter access, representing a promising advancement in medical device technology.